NK
Neeraj Kumar
About Neeraj Kumar
Data last updated:
Neeraj Kumar is a Director at Hippocrat Biotech Private Limited (since 2017), Director at Biorealm Biopharmaceuticals Private Limited (since 2013) and Director at Hippocrat Dialysis Services Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹24.31 Cr; the largest is Hippocrat Biotech Private Limited at ₹19.07 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hippocrat Biotech Private Limited U24233MH2013PTC241122 | Director | 29 Jul 2017 | 2013 | ₹19.07 Cr (FY 2024) | Active |
| Biorealm Biopharmaceuticals Private Limited U24299MH2013PTC250679 | Director | 03 Dec 2013 | 2013 | ₹5.25 Cr (FY 2024) | Active |
| Hippocrat Dialysis Services Private Limited U86100MH2023PTC410342 | Director | 13 Sep 2023 | 2023 | Active | |
| Hippocrat Biomedical Llp ACC-8544 | Designated Partner | 05 Sep 2023 | 2023 | Active |
Board colleagues of Neeraj Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Suneeta Devi | 06469316 | Hippocrat Biotech Private Limited , Biorealm Biopharmaceuticals Private Limited and 1 more | Director |
| Bhanwarlal Choudhary | 06714130 | Biorealm Biopharmaceuticals Private Limited | Director |
| Aditya Pratap Singh | 07973002 | Hippocrat Biomedical Llp | Designated Partner |
| Kailash Gongaji Choudhari | 10307795 | Hippocrat Biomedical Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Neeraj Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neeraj Kumar
Neeraj Kumar currently holds 4 directorships: Hippocrat Biotech Private Limited (Director, since 29 Jul 2017, revenue ₹19.07 Cr (FY 2024)); Biorealm Biopharmaceuticals Private Limited (Director, since 03 Dec 2013, revenue ₹5.25 Cr (FY 2024)); Hippocrat Dialysis Services Private Limited (Director, since 13 Sep 2023); Hippocrat Biomedical Llp (Designated Partner, since 05 Sep 2023).
Neeraj Kumar was first appointed on 03 Dec 2013 as Director at Biorealm Biopharmaceuticals Private Limited. The most recent appointment on record is 13 Sep 2023 at Hippocrat Dialysis Services Private Limited.
The 2 current companies of Neeraj Kumar that report revenue have a combined latest revenue of ₹24.31 Cr: Hippocrat Biotech Private Limited ₹19.07 Cr (FY 2024); Biorealm Biopharmaceuticals Private Limited ₹5.25 Cr (FY 2024).
The current boards of Neeraj Kumar's companies include Suneeta Devi (Hippocrat Biotech Private Limited), Bhanwarlal Choudhary (Biorealm Biopharmaceuticals Private Limited), Aditya Pratap Singh (Hippocrat Biomedical Llp), Kailash Gongaji Choudhari (Hippocrat Biomedical Llp).